The table below shows CG Oncology, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$1.08M
$1.67M
$0.00
$52.00K
$43.00K
$111.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$43.73M
$27.88M
$31.33M
$27.47M
$19.62M
$18.47M
SG&A
CGON annual revenue (10-K history)
CG Oncology, Inc. reported annual revenue of $4.04M for fiscal year 2025. That is up 254.7% from $1.14M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.